Navigation Links
BioMed Realty Trust Announces Tax Treatment of 2008 Distributions
Date:1/20/2009

SAN DIEGO, Jan. 20 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2008 distributions as follows:

                   Security Description: Common Stock
                          CUSIP: 09063H107
                         Ticker Symbol: BMR

                                    Total                    Taxable
       Record       Payable     Distribution   Allocable     Ordinary
        Date         Date         Per Share     to 2008      Dividend

     12/31/2007    1/15/2008      $0.310000    $0.310000     $0.198099
      3/31/2008    4/15/2008      $0.335000    $0.335000     $0.214074
      6/30/2008    7/15/2008      $0.335000    $0.335000     $0.214074
      9/30/2008    10/15/2008     $0.335000    $0.335000     $0.214074
             Totals               $1.315000    $1.315000     $0.840321


                                              Long-Term    Unrecaptured
      Record       Payable       Return of     Capital     Section 1250
       Date          Date         Capital        Gain          Gain

     12/31/2007    1/15/2008     $0.111901     $0.000000     $0.000000
      3/31/2008    4/15/2008     $0.120926     $0.000000     $0.000000
      6/30/2008    7/15/2008     $0.120926     $0.000000     $0.000000
      9/30/2008    10/15/2008    $0.120926     $0.000000     $0.000000
             Totals              $0.474679     $0.000000     $0.000000


        Security Description: 7.375% Series A Cumulative Redeemable
                             Preferred Stock
                              CUSIP: 09063H206
                          Ticker Symbol: BMR PR A

                                   Total                Taxable
       Record       Payable    Distribution  Allocable  Ordinary
        Date         Date        Per Share    to 2008   Dividend

     12/31/2007    1/15/2008     $0.460940   $0.460940   $0.460940
      3/31/2008    4/15/2008     $0.460940   $0.460940   $0.460940
      6/30/2008    7/15/2008     $0.460940   $0.460940   $0.460940
      9/30/2008    10/15/2008    $0.460940   $0.460940   $0.460940
             Totals               $1.84376    $1.84376    $1.84376


                                            Long-Term   Unrecaptured
       Record      Payable      Return of     Capital   Section 1250
        Date         Date         Capital      Gain        Gain

     12/31/2007    1/15/2008     $0.000000   $0.000000   $0.000000
      3/31/2008    4/15/2008     $0.000000   $0.000000   $0.000000
      6/30/2008    7/15/2008     $0.000000   $0.000000   $0.000000
      9/30/2008    10/15/2008    $0.000000   $0.000000   $0.000000
             Totals              $0.000000   $0.000000   $0.000000


The distributions payable on January 15, 2009 to shareholders of record on December 31, 2008, as previously announced on December 15, 2008, are considered 2009 distributions for federal income tax purposes.

The company did not incur any foreign taxes during 2008. In addition, only for purposes of calculating alternative minimum taxable income under Section 55 of the Internal Revenue Code of 1986, as amended, the company apportions $0.0009 per common share and Series A preferred share attributable to depreciation, each assuming a full year of ownership. Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 69 properties, representing 112 buildings with approximately 10.4 million rentable square feet, including approximately 1.4 million square feet of development in progress. The company also owns undeveloped land parcels adjacent to existing properties that it estimates can support up to 1.4 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.


'/>"/>
SOURCE BioMed Realty Trust, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alpine Biomed Acquires Stellate to Create New Leader in Neurology Diagnostics Market
2. BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer
3. Collexis BiomedExperts Hits 80,000 Registered Users Within the First Year!
4. 5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
5. Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference
6. Response Biomedical Corporation Announces Change of Executives
7. AutismActionPlan.org Launches Doctor-Driven Biomedical Autism Treatment Website
8. LA BioMed researchers among Southern California Super Doctors
9. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
10. ASH Honors Speaker of the House Nancy Pelosi and NHLBI Deputy Director Susan Shurin, MD, for Their Public Service, Leadership, and Commitment to Biomedical Research
11. Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed ... geared towards children of all ages; it is a non-competitive, non-timed event, which is ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... -- AVACEN Medical , Inc. (AVACEN) announced that Frost ... Product Innovation Award for Its fibromyalgia pain management device. ... device market research by Frost & Sullivan,s industry experts. ... relief product, the AVACEN 100, offers a safe and effective ... ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
Breaking Medicine Technology: